Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06483750 · ClinicalTrials.gov registry record · NA
Preoperative iLux on Cataract Surgery Derived Dry Eye Disease Due to Meibomian Gland Dysfunction
A NA study, sponsored by George Washington University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT06483750 is a NA study that has completed, run by George Washington University. The registered enrollment target is 30 participants.
The verdict
NCT06483750, a NA study, has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This prospective study will investigate the effect of pre-operative Systane iLux system administration in treated cataract induced dry eye disease.
Interventions
- DEVICE Systane iLux Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-06-03 |
| Est. Completion | 2025-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06483750
The ClinicalTrials.gov registry entry for NCT06483750 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Systane iLux Treatment is the first listed.
NCT06483750 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06483750 about?
NCT06483750 is a clinical study titled "Preoperative iLux on Cataract Surgery Derived Dry Eye Disease Due to Meibomian Gland Dysfunction". This prospective study will investigate the effect of pre-operative Systane iLux system administration in treated cataract induced dry eye disease.
What is the current status of trial NCT06483750?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2024-06-03. Estimated completion is 2025-02-01.
What interventions are being tested in trial NCT06483750?
The interventions under investigation include: Systane iLux Treatment (DEVICE).
Who is sponsoring clinical trial NCT06483750?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.